Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02368483
Other study ID # FAI conservative treatment 1
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 2014
Est. completion date March 2017

Study information

Verified date June 2019
Source Schulthess Klinik
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a single-group, prospective, intervention study. A total of 30 participants with unilateral symptomatic femoroacetabular impingement will be included into the study. The intervention consists in neuromuscular training for the lower limb muscles (12 weeks, 2 times/week supervised training, 2 times/week home training). The training includes physical exercises routinely used worldwide in clinical settings. No control intervention group was included into the study because nowadays there is no standard conservative treatment for patients with symptomatic femoroacetabular impingement. Assessments will be performed at (1) baseline, (2) mid-intervention, (3) end-intervention, and (4) follow-up. Clinical, functional, neuromuscular and self-reported parameters will be collected during assessments.


Recruitment information / eligibility

Status Completed
Enrollment 34
Est. completion date March 2017
Est. primary completion date March 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years to 35 Years
Eligibility Inclusion Criteria:

- Diagnosis of unilateral symptomatic FAI according to clinical, radiographic and magnetic resonance imaging criteria

- Living place: Canton of Zurich or neighbouring Cantons

- Signed written informed consent to participate into the study

Exclusion Criteria:

- Previous hip surgery

- Any surgery to the lower limbs in the prior 6 months

- Congenital/developmental dysplasia

- Hip osteoarthritis

- Initiation of opioid analgesia and corticosteroid injection for hip pain within the prior 30 days

- BMI >35 kg/m2

- Significant cardiorespiratory diseases

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Neuromuscular training
Neuromuscular training for the hip and lower limb muscles.The training program is divided into 3 phases, and includes specific exercises for improving the hip range of motion, muscle strength of the hip and lower limb muscles, as well as the trunk stability and coordination. The intervention lasts 12 weeks. Patients will train 2 times/week with a physical therapist and 2 times/weeks alone at home.

Locations

Country Name City State
Switzerland Schulthess Clinic Zurich

Sponsors (1)

Lead Sponsor Collaborator
Schulthess Klinik

Country where clinical trial is conducted

Switzerland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Hip Function as measured using the Hip Outcome Score questionnaire Hip Function was assessed using the Hip Outcome Score. The Hip Outcome score is a questionnaire used to evaluate hip function during daily and sport activities. Two independent scores are obtained: one for activities of daily living and one for sport activities. Change from Baseline in Hip Function at 12 weeks
Secondary Hip Muscle Strength as measured using dynamometry Hip abduction, adduction, internal rotation and external rotation isometric maximal voluntary contraction strength is evaluated with hand-held dynamometry. Hip flexion and extension isometric maximal voluntary contraction strength is evaluated with isokinetic dynamometry. Change from Baseline in Hip Muscle Strength at 12 weeks
Secondary Movement Control Quality as measured using a visual rating scale Overall body movement pattern quality is visually assessed during the performance of 5 lower extremity functional tests (single-leg squat, lunge, hop lunge, single-leg bridge, single-leg ventral plank). Change from Baseline in Movement Control Quality at 12 weeks